Adagio Therapeutics, Inc. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (3)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on March 28, 2024)
- Controlled Equity OfferingSM Sales Agreement by and between the Company and Cantor Fitzgerald & Co., dated December 22, 2023 (Filed With SEC on December 22, 2023)
- Second Amended and Restated Commercial Manufacturing Services Agreement by and between the Company and WuXi Biologics (Hong Kong) Limited, dated September 19, 2023 (Filed With SEC on November 9, 2023)
- Amendment Number Two to the Collaboration Agreement by and between the Company and Adimab, LLC, dated September 19, 2023 (Filed With SEC on November 9, 2023)
- Amended and Restated Commercial Manufacturing Services Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated August 12, 2021 (Filed With SEC on November 15, 2021)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on August 2, 2021)
- Commercial Manufacturing Services Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 24, 2020 (Filed With SEC on July 16, 2021)
- Collaboration Agreement by and between the Registrant and Adimab, LLC, dated May 21, 2021 (Filed With SEC on July 16, 2021)
